Edward Liddy Net Worth

The estimated Net Worth of Edward M Liddy is at least $2.24 Million dollars as of 14 August 2017. Mr. Liddy owns over 1,185 units of Abbott Laboratories stock worth over $1,913,610 and over the last 16 years he sold ABT stock worth over $0. In addition, he makes $325,977 as Independent Director at Abbott Laboratories.

Mr. Liddy ABT stock SEC Form 4 insider trading

Edward has made over 10 trades of the Abbott Laboratories stock since 2004, according to the Form 4 filled with the SEC. Most recently he bought 1,185 units of ABT stock worth $58,018 on 14 August 2017.

The largest trade he’s ever made was exercising 646,788 units of Abbott Laboratories stock on 7 December 2006 worth over $24,888,402. On average, Edward trades about 11,479 units every 25 days since 2003. As of 14 August 2017 he still owns at least 22,967 units of Abbott Laboratories stock.

You can see the complete history of Mr. Liddy stock trades at the bottom of the page.

Edward Liddy biography

Edward M. (Ed) Liddy serves as Independent Director of the Company. Mr. Liddy served as a partner in the private equity investment firm Clayton, Dubilier & Rice, LLC from January 2010 to December 2015. At the request of the Secretary of the U.S. Department of Treasury, Mr. Liddy served as Interim Chairman and Chief Executive Officer of American International Group, Inc., a global insurance and financial services holding company, from September 2008 until August 2009. From January 1999 to April 2008, Mr. Liddy served as Chairman of the Board of the Allstate Corporation. He served as Chief Executive Officer of Allstate from January 1999 to December 2006, President from January 1995 to May 2005, and Chief Operating Officer from August 1994 to January 1999. Mr. Liddy currently serves on the Board of Directors of AbbVie Inc., 3M Company, and The Boeing Company. Through his executive leadership at Allstate and American International Group, and his board service at several Fortune 100 companies across a broad range of industries, Mr. Liddy provides valuable insights on corporate strategy, risk management, corporate governance and many other issues facing large, global enterprises. Additionally, as a former chief financial officer, audit committee chair at Goldman Sachs and 3M Company, and partner at Clayton, Dubilier & Rice, LLC, Mr. Liddy provides significant knowledge and understanding of corporate finance, capital markets, financial reports and accounting matters.

What is the salary of Edward Liddy?

As the Independent Director of Abbott Laboratories, the total compensation of Edward Liddy at Abbott Laboratories is $325,977. There are 11 executives at Abbott Laboratories getting paid more, with Miles White having the highest compensation of $24,254,200.

How old is Edward Liddy?

Edward Liddy is 73, he’s been the Independent Director of Abbott Laboratories since 2010. There are 1 older and 16 younger executives at Abbott Laboratories. The oldest executive at Abbott Laboratories is Samuel Scott, 74, who is the Independent Director.

What’s Edward Liddy’s mailing address?

Edward’s mailing address filed with the SEC is 3M CENTER, , MAPLEWOOD, MN, 55144.

Insider trading at Abbott Laboratories

Over the last 19 years, insiders at Abbott Laboratories have traded over $300,124,202 worth of Abbott Laboratories stock and bought 1,026,437 units worth $44,673,718 . The most active insider traders include Miles D White, Richard A Gonzalez, and Glenn F Tilton. On average, Abbott Laboratories executives and independent directors trade stock every 8 days with the average trade being worth of $3,036,946. The most recent stock trade was executed by Randel William Woodgrift on 23 October 2019, trading 21,000 units of ABT stock currently worth $1,691,340.

What does Abbott Laboratories do?

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

What does Abbott Laboratories’s logo look like?

Complete history of Mr. Liddy stock trades at 3M Co, Abbott Laboratories, AbbVie, The Allstate, The Boeing Co, and The Kroger Co

Abbott Laboratories executives and stock owners

Abbott Laboratories executives and other stock owners filed with the SEC include:

  • Miles White, Chairman of the Board, Chief Executive Officer
  • Robert Ford, President, Chief Operating Officer
  • Brian Yoor, Chief Financial Officer, Executive Vice President – Finance
  • Hubert Allen, Executive Vice President, General Counsel, Secretary
  • Daniel Salvadori, Senior Vice President – Established Pharmaceuticals, Latin America.
  • Robert Alpern, Independent Director
  • Sally Blount, Independent Director
  • Glenn Tilton, Independent Director
  • Samuel Scott, Independent Director
  • William Osborn, Lead Independent Director
  • Roxanne Austin, Independent Director
  • Edward Liddy, Independent Director
  • Nancy McKinstry, Independent Director
  • Phebe Novakovic, Independent Director
  • John Stratton, Independent Director
  • Daniel Starks, Independent Director
  • Michelle Kumbier, Independent Director
  • Darren McDew, Director
  • Jaime Contreras, Senior Vice President – Core Laboratory Diagnostics, Commercial Operations
  • Jared Watkin, Senior Vice President
  • Andrew H Lane, Senior Vice President
  • Robert E Funck, Senior Vice President
  • Sean Shrimpton, Senior Vice President
  • John M Capek, Executive Vice President
  • Deepak S. Nath, Senior Vice President
  • Joseph J Manning, Senior Vice President
  • Roger Bird, Senior Vice President
  • Brian J Blaser, Senior Vice President
  • Stephen R Fussell, Senior Vice President
  • Michael J Warmuth, Senior Vice President
  • Eric S Fain, Senior Vice President
  • Lisa D Earnhardt, Executive Vice President
  • Sharon J Bracken, Senior Vice President
  • Michael T Rousseau, Pres., Cardiovasc. & Neuromod.
  • Charles Brynelsen, Senior Vice President
  • Michael J Pederson, Senior Vice President
  • Alejandro D Wellisch, Senior Vice President
  • Sammy Karam, Senior Vice President
  • Randel William Woodgrift, Senior Vice President
  • Christopher J Scoggins, Senior Vice President
  • Richard W Ashley, Executive Vice President
  • Andrea F Wainer, Executive Vice President
  • John F Ginascol, Executive Vice President
  • Jean Yves Pavee, Senior Vice President
  • W James Farrell, Director
  • Thomas C Freyman, Senior Vice President
  • Georges H. De Vos, Senior Vice President
  • Katherine C. Doyle, Senior Vice President
  • J. Scott White, Senior Vice President
  • Charles D Foltz, Senior Vice President
  • Murthy V Simhambhatla, Senior Vice President
  • Thomas G Frinzi, Senior Vice President
  • John C Landgraf, Senior Vice President
  • Greg W Linder, Vice President
  • Heather L Mason, Senior Vice President
  • Paul K Magill, Senior Vice President
  • A. David Forrest, Senior Vice President
  • H Laurance Fuller, Director
  • Carlos Alban, Senior Vice President
  • James V Mazzo, Senior Vice President
  • Holger A Liepmann, Senior Vice President
  • William D Smithburg, Director
  • Laura J Schumacher, Senior Vice President
  • David Owen, Director
  • Edward L Michael, Senior Vice President
  • Richard A Gonzalez, Chief Operating Officer
  • Donald V Jr Patton, Senior Vice President
  • William M Daley, Director
  • Robert B Hance, Senior Vice President
  • Mary T Szela, Senior Vice President
  • Roy S Roberts, Director
  • Corlis D Murray, Senior Vice President
  • Thomas F Chen, Senior Vice President
  • Olivier Bohuon, Senior Vice President
  • James L Tyree, Senior Vice President
  • W Ann Reynolds, Director
  • Boone Jr Powell, Director
  • Mary K Moreland, Executive Vice President
  • Edward J Fiorentino, Senior Vice President
  • Gary E Mccullough, Senior Vice President
  • Jeffrey M Leiden, President & COO
  • Jack M Greenberg, Director
  • Joseph M Nemmers, Senior Vice President
  • John R Walter, Director
  • Jeffrey R Binder, Senior Vice President
  • William G Dempsey, Senior Vice President
  • A Barry Rand, Director
  • Thomas M Wascoe, Senior Vice President
  • Christopher B Begley, Senior Vice President
  • Lance B Wyatt, Senior Vice President
  • Guillermo A Herrera, Senior Vice President
  • Lasa Jose M De, Senior Vice President